U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494773) titled 'Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection' on March 17.
Brief Summary: Burn wound infections remain a major source of morbidity in patients with thermal injuries and contribute to delayed healing, graft loss, and prolonged hospitalization. The emergence of antimicrobial-resistant organisms further complicates management and highlights the need for non-antibiotic antimicrobial strategies. Photodynamic therapy (PDT) is an antimicrobial approach that combines a photosensitizing agent with visible light to generate reactive oxygen species capable of killing bacteria.
This randomized clinical trial w...